Palo Alto-based cancer test developer Guardant Health cuts 130 jobs
January 26, 2023 at 10:13 AM EST
The move comes about a month after the company's stock dropped by about 30% when it reported trial results of a test for colorectal cancer that disappointed some of its investors.
